A single high dose of idarubicin combined with high dose ARA-C for the treatment of first recurrence childhood “high risk” acute lymphoblastic leukemia (ALL).

Authors
Publication date
1 January 2000
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio della ricerca- Università di Roma La Sapienza

    redirect
    oaioai:iris.uniroma1.it:11573/420...
    Last time updated on 12/11/2016